WallStreetZenWallStreetZen

NASDAQ: IONS
Ionis Pharmaceuticals Inc Stock Ownership - Who owns Ionis Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Ionis Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Brian BirchlerEVP Corp and Development Ops2024-04-16905$41.66
$37.70kSell
Joseph BaroldiEVP Chief Business Officer2024-04-164,006$41.60
$166.64kSell
Eric SwayzeOfficer Level 142024-02-29605$34.43
$20.83kBuy
Brian BirchlerVice President Level 142024-02-29604$34.43
$20.79kBuy
Brett P. MoniaCEO Level 152024-02-29538$34.43
$18.52kBuy
C. Frank BennettOfficer Level 142024-02-29383$34.43
$13.18kBuy
Richard S. GearyOfficer Level 142024-02-29604$34.43
$20.79kBuy
Brett P. MoniaChief Executive Officer2024-02-16387$44.49
$17.22kSell
Elizabeth L. HougenEVP Finance CFO2024-02-022,125$49.54
$105.27kSell
Eugene SchneiderEVP Chf Clinical Develop Ofcr2024-02-022,071$49.59
$102.70kSell

1 of 9

IONS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IONS insiders and whales buy or sell their stock.

IONS Shareholders

What type of owners hold Ionis Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC14.77%21,520,872$895.05MInstitution
Vanguard Group Inc9.74%14,203,481$590.72MInstitution
T Rowe Price Investment Management Inc9.06%13,201,453$549.05MInstitution
Blackrock Inc6.21%9,057,530$376.70MInstitution
Bellevue Group Ag5.98%8,713,987$362.41MInstitution
Clearbridge Investments LLC3.23%4,707,480$195.78MInstitution
Wellington Management Group LLP3.17%4,616,978$192.02MInstitution
Price T Rowe Associates Inc2.92%4,255,074$176.97MInstitution
State Street Corp2.75%4,008,797$166.73MInstitution
Pictet Asset Management Holding Sa2.41%3,518,317$146.33MInstitution

1 of 3

IONS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IONS96.31%3.69%Net SellingNet Selling
APLS74.88%25.12%Net BuyingNet Selling
RVMD89.46%10.54%Net SellingNet Selling
BPMC81.64%18.36%Net SellingNet Selling
PCVX83.78%16.22%Net BuyingNet Buying
View Top Biotech Stocks

Ionis Pharmaceuticals Stock Ownership FAQ

Who owns Ionis Pharmaceuticals?

Ionis Pharmaceuticals (NASDAQ: IONS) is owned by 97.65% institutional shareholders, 3.74% Ionis Pharmaceuticals insiders, and 0.00% retail investors. Lilly Co Eli is the largest individual Ionis Pharmaceuticals shareholder, owning 2.50M shares representing 1.72% of the company. Lilly Co Eli's Ionis Pharmaceuticals shares are currently valued at $103.98M.

If you're new to stock investing, here's how to buy Ionis Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.